Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness

International Journal of Infectious Diseases

Volumn 12, Issue 2, 2008, Pages 183-189

  de la Hoz, Fernando ^a   Perez, Ligia ^b   de Neira, Marlen ^c   Hall, Andrew J ^d  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^b Secretaria de Salud del Amazonas   (Colombia)

^c INSTITUTO NACIONAL DE SALUD   (Colombia)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Colombia; Effectiveness; Epidemiology; Hepatitis B; Vaccine

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; RECOMBINANT VACCINE;

ARTICLE; BIRTH; CHILD; CLUSTER ANALYSIS; COLOMBIA; DISEASE ASSOCIATION; DISEASE MARKER; DRUG EFFICACY; ENDEMIC DISEASE; FEMALE; HEALTH PROMOTION; HEPATITIS B; HETEROZYGOTE DETECTION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTHER; PREVALENCE; SEROLOGY; VACCINATION; VIRUS INFECTION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COLOMBIA; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; IMMUNIZATION SCHEDULE; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; RURAL POPULATION; URBAN POPULATION; VACCINES, SYNTHETIC;

EID: 39149124128     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2007.06.010     Document Type: Article

References (32)

1. Hadler S., and Margolis H. Epidemiology of hepatitis B virus infection. In: Ellis R. (Ed). Hepatitis B vaccines in clinical practice (1993), Marcel Dekker, New York 141-157
2. Hall A.J. Control of hepatitis B by childhood vaccination. Rev Med Microbiol 5 (1994) 123-130
3. Kane M. Global program for control of hepatitis B infection. Vaccine 13 Suppl 1 (1995) S47-S49
4. Gast Galvis A. Hepatitis febril de Santa Marta. Salubridad 12 (1955) 1145-1152
5. Buitrago B., Popper H., Hadler S., Thung S.N., Gerber M.A., Purcell R.H., et al. Specific histopathological features of Santa Marta hepatitis: a severe form of hepatitis delta infection in Northern South America. Hepatology 6 (1986) 1285-1291
6. Buitrago B., Hadler S., Popper H., Thung S.N., Gerber M.A., Purcell R.H., et al. Epidemic aspects of Santa Marta hepatitis over a 40-year period. Hepatology 6 (1986) 1292-1296
7. Martinez M., De la Hoz F., Jaramillo L.S., Rojas M.C., Buitrago B., Boshell J., et al. Seroepidemiologia de la infeccion por el virus de la hepatitis B en ninos de la Amazonia Colombiana. Biomédica 11 (1991) 20-24
8. Ljunggren K.E., Patarroyo M.E., Engle R., Purcell R.H., and Gerin J.L. Viral hepatitis in Colombia: A study of the "hepatitis of the Sierra Nevada de Santa Marta". Hepatology 5 (1985) 299-304
9. Juliao O. Prevalencia de antígeno de superficie en Colombia. Estudio nacional de salud 1980. Biomédica 11 (1991) 56-60
10. Cristancho LM. Epidemiología de la infección por el virus de la hepatitis B en el departamento del Amazonas. Tesis de grado. Maestría en Salud Pública. Universidad del Valle; 1993.
11. González-Griego Mde J., Cinza Z., Ortega A., Gali M.M., Santoyo M.E., García G., et al. Estudio comparativo entre diferentes esquemas de administración de 2 dosis con la vacuna cubana antihepatitis B. Rev Cubana Med Trop 50 (1998) 218-220
12. Slusarczyk J., and Magdzik J. Regional workshops on hepatitis A and B prevention and control. Vaccine 18 (2000) S97-S114
13. Tambini G., Suang Mung K.S., and Raad J. Hepatitis B: situación mundial y regional. Biomédica 18 (1998) 169-174
14. Cabezas C., Ramos F., Vega M., Suárez M., Romero G., Carrillo C., et al. Impacto del programa de vacunación contra hepatitis viral B (VHB) integrado al programa ampliado de inmunizaciones (PAI) en Huanta (Perú), 1994-1997. Rev Gastroenterol Peru 20 (2000) 201-212
15. Cabezas C., Echeverria C., Gomez G., and Gotuzzo E. Programa piloto de inmunización contra hepatitis viral B integrado al programa ampliado de inmunizaciones (PAI) en Abancay (Perú). Rev Gastroenterol Peru 15 (1995) 215-222
16. Wilson N., Ruff T., Rana B., Leydon J., and Locarnini S. The effectiveness of the infant hepatitis B immunisation program in Fiji, Kiribati, Tonga and Vanatu. Vaccine 18 (2000) 3059-3066
17. Tsebe K., Burnett R., Hlungwani N., Sibara M., Venter P., and Mphahlele M. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds. Vaccine 19 (2001) 3919-3926
18. Mahoney F., and Kane M. Hepatitis B vaccine. In: Plotkin S.A., and Orenstein W.A. (Eds). Vaccines. 3rd ed. (1999), WB Saunders Co., Philadelphia 158-182
19. Mahoney F. Update on diagnosis, management and prevention of hepatitis B virus infection. Clin Microbiol Rev 12 (1999) 351-366
20. Shapiro C., and Margolis H. Impact of hepatitis B virus infection on women and children. Infect Dis Clin North Am 6 (1992) 75-96
21. Botha J., Ritchie M., Dusheiko G., and Mouton H. Hepatitis B virus carrier state in black children in Ovamboland: role of perinatal and horizontal infection. Lancet 1 (1984) 1210-1212
22. Miranda Braga W., Brasil L., Botelho de Souza R., Castilho M., and Fonseca J. Ocorrencia da infeccao pelo virus da hepatite B (VHB) e delta (VHD) em sete grupos indigenas do Estado do Amazonas. Rev Soc Bras Med Trop 34 (2001) 349-355
23. Hino K., Katoh Y., Vardas E., Sim J., Okita K., and Carman W. The effect of introduction of universal childhood hepatitis B immunisation in South Africa on the prevalence of serologically negative hepatitis B virus infection and the selection of immune escape variants. Vaccine 19 (2001) 3912-3918
24. Inskip H., Hall A., Chotard J., Loik F., and Whittle H. Hepatitis B vaccine in the Gambian expanded program on immunization: factors influencing antibody response. Int J Epidemiol 20 (1991) 765-769
25. Hadler S., Monzon M.A., Rivero D., and Perez M. Effect of timing of hepatitis B vaccine doses on response to vaccine in Yucpa Indians. Vaccine 7 (1989) 106-110
26. Ruff T., Gertig D., Otto B., Gust I.D., Sutanto A., Soewarso T.I., et al. Lombok Hepatitis B Model Immunization Project: toward universal infant hepatitis B immunization in Indonesia. J Infect Dis 171 (1995) 290-296
27. Lin D., Wang H., Lee Y., Ling U., Changlai S., and Chen C.J. Immune status in preschool children after mass hepatitis B vaccination program in Taiwan. Vaccine 16 (1998) 1683-1687
28. Poovorawan Y., Theamboonlers A., Vimolket T., Sinlaparatsamee S., Chaiear K., Siraprapasiri T., et al. Impact of hepatitis B immunization as part of the EPI. Vaccine 19 (2001) 943-949
29. Stevens C., Toy P., Taylor P., Lee T., and Yip H. Prospects for control of hepatitis B virus infection: implications of childhood vaccination and long term protection. Pediatrics 90 (1992) 170-173
30. del Canho R., Grosheide P., Mazel J., Heijtink R.A., Hop W.C., Gerards L.J., et al. Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long term immunogenicity. Vaccine 15 (1997) 1624-1630
31. Alves A., Nascimento C., Granato C., Sato H., Morgato M., and Pannutti C. Hepatitis B vaccine in infants: a randomized controlled trial comparing gluteal versus anterolateral thigh muscle administration. Rev Inst Med Trop S Paulo 43 (2001) 139-143
32. Fessard C., Riche O., and Cohen H.M. Intramuscular versus subcutaneous injection for hepatitis B vaccine. Vaccine 6 (1998) 469